Monitor the shareholder vote on May 29, 2026. If approved, the consolidation will take effect in early June, proportionally adjusting the share price. The potential dilution from option grants and the incentive plan is significant but contingent on shareholder approval and future exercise.
Price Chart
Executive Summary
Alterity Therapeutics filed a 6-K with a Notice of General Meeting scheduled for May 29, 2026, seeking shareholder approval for a 50:1 share consolidation, election of two directors, issuance of options to directors and a related party, an increase in the incentive plan issue cap, and approval to issue up to 1.09 billion securities under an employee incentive plan. This is a routine procedural filing with no immediate financial results or change in business fundamentals.
Key Facts
- General Meeting scheduled for May 29, 2026 to vote on 7 resolutions.
- Proposed 50:1 consolidation of issued capital, reducing shares from 10.88B to 217.5M.
- Approval sought to issue 100M options (pre-consolidation) to director Julian Babarczy.
- Approval sought to issue 50M options (pre-consolidation) to Montoya Pty Ltd, an entity associated with director Lawrence Gozlan.
- Approval sought to issue up to 1,087,541,633 securities (pre-consolidation) under a new Employee Incentive Securities Plan.
- Directors recommend voting in favor of all resolutions.
Financial Impact
The consolidation does not change equity value; option grants could cause dilution if exercised but are subject to approval. No immediate financial impact from this filing.
Risk Factors
- Dilution if all options and incentive plan securities are exercised.
- Share consolidation may signal low stock price issues, though typical for development-stage biotechs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-013732 |
| Document: athe20260429_6k.htm | 0001437749-26-013732 |
| Document: 0001437749-26-013732-index-headers.html | 0001437749-26-013732 |
| Document: 0001437749-26-013732-index.html | 0001437749-26-013732 |
| Document: 0001437749-26-013732.txt | 0001437749-26-013732 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 9, 2026 20w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▼ −1.39% | $0.2500 (+354.55%) |
Jun 4, 2026 20w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▲ +1.37% | $0.2500 (+354.55%) |
Jun 3, 2026 20w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▲ +1.00% | $0.2500 (+354.55%) |
May 29, 2026 21w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▲ +1.79% | $0.2500 (+354.55%) |
Apr 30, 2026 25w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▼ −5.23% | $0.2500 (+354.55%) |
Apr 29, 2026 25w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −6.05% | $0.2500 (+22627.27%) |
Apr 27, 2026 26w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.95% | $0.2500 (+22627.27%) |
Apr 22, 2026 26w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.22% | $0.2500 (+22627.27%) |
Apr 21, 2026 27w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.21% | $0.2500 (+22627.27%) |
Apr 20, 2026 27w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.22% | $0.2500 (+22627.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers